Antibiotic Treatment for Sinusitis
For adults with acute bacterial sinusitis, amoxicillin-clavulanate is the recommended first-line antibiotic, though recent high-quality evidence suggests standard-dose amoxicillin alone may be equally effective with fewer adverse effects. For children, amoxicillin-clavulanate remains the clear first choice 1.
When to Start Antibiotics
Initiate antibiotics only when acute bacterial rhinosinusitis (ABRS) is diagnosed, which requires one of these criteria 1:
- Symptoms persisting ≥10 days without improvement
- "Double worsening": initial improvement followed by worsening within 10 days
- Severe symptoms (high fever ≥39°C and purulent nasal discharge) for ≥3-4 consecutive days
Most acute sinusitis is viral and resolves without antibiotics—approximately 80% of patients improve within two weeks without treatment 2.
First-Line Antibiotic Regimens
For Children
Amoxicillin-clavulanate 90 mg/kg/day (of amoxicillin component) divided twice daily is strongly recommended 1. This high-dose formulation addresses increasing pneumococcal resistance.
Duration: 10-14 days 1
For Adults
The evidence has evolved significantly:
Traditional guideline recommendation: Amoxicillin-clavulanate 875-125 mg twice daily (though this is a weak recommendation with low-quality evidence) 1
However, the most recent and highest quality evidence from 2026 challenges this: A large retrospective cohort study of 234,608 adults found no difference in treatment failure between amoxicillin-clavulanate and amoxicillin alone (3.0% vs 3.1%, RR 0.96) 3. Critically, amoxicillin-clavulanate was associated with significantly higher rates of yeast infections (1.1% vs 0.8%) and C. difficile infections (0.04% vs 0.02%) 3.
Practical recommendation: Standard-dose amoxicillin 875 mg twice daily or 500 mg three times daily is reasonable first-line therapy for uncomplicated ABRS in adults, reserving amoxicillin-clavulanate for treatment failures or patients with risk factors for resistance 3.
Duration: 5-7 days for adults 1
High-Dose Therapy Considerations
High-dose amoxicillin-clavulanate (2 g twice daily for adults, 90 mg/kg/day for children) is recommended when 1:
- Geographic areas with high rates (>10%) of penicillin-resistant S. pneumoniae
- Severe infection
- Recent antibiotic use within past month
- Age <2 or >65 years
- Daycare attendance
- Immunocompromised state
Important caveat: A 2018 RCT found that immediate-release high-dose formulations led to faster improvement but also significantly more severe diarrhea (15.8% vs 4.8%), while extended-release high-dose showed no benefit 4.
Beta-Lactam Allergy Alternatives
For patients with penicillin allergy:
- Doxycycline 100 mg twice daily (for mild disease)
- Levofloxacin 500 mg daily or moxifloxacin 400 mg daily (for moderate disease or beta-lactam hypersensitivity) 1, 5
Reserve fluoroquinolones for genuine penicillin allergy due to resistance concerns and FDA warnings about serious adverse effects.
Second-Line Therapy
Switch antibiotics if no improvement after 72 hours or worsening occurs 1, 5. Consider:
- Amoxicillin-clavulanate (if amoxicillin was used initially)
- Respiratory fluoroquinolones (levofloxacin, moxifloxacin)
Do NOT routinely cover for MRSA during initial empiric therapy—current data do not support this practice 1.
Adjunctive Therapies
Recommended:
- Intranasal corticosteroids (especially with allergic rhinitis history) 1
- Nasal saline irrigation (physiologic or hypertonic) 1
- Analgesics based on pain severity 6
NOT recommended:
Critical Pitfalls to Avoid
- Overdiagnosis: Most "sinusitis" is viral rhinosinusitis—wait for the 10-day threshold or double worsening before diagnosing ABRS
- Imaging overuse: CT or X-rays are NOT needed for uncomplicated ABRS diagnosis 6
- Excessive duration: Adults need only 5-7 days, not the traditional 10-14 days
- Automatic use of amoxicillin-clavulanate: The 2026 data suggests plain amoxicillin may be equally effective with fewer adverse effects in adults 3
- Ignoring treatment failure: Reassess at 7 days if no improvement 6
When to Refer
Refer to otolaryngology for:
- Failure to respond to appropriate antibiotic therapy
- Recurrent episodes (≥4 per year)
- Signs of complications (orbital or intracranial extension, severe headache, visual changes, altered mental status)
- Chronic rhinosinusitis (symptoms >12 weeks)
The key tension in current evidence is between established guidelines favoring amoxicillin-clavulanate 1 and the most recent, large-scale real-world evidence showing equivalent efficacy with plain amoxicillin and fewer adverse effects 3. Given the priority on minimizing morbidity (secondary infections, adverse effects) while maintaining efficacy, amoxicillin alone represents a reasonable and potentially superior first-line choice for uncomplicated ABRS in adults.